English  |  正體中文  |  简体中文  |  Items with full text/Total items : 12274/13174 (93%)
Visitors : 1767039      Online Users : 201
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version
    Please use this identifier to cite or link to this item: http://ir.nhri.org.tw/handle/3990099045/13400


    Title: A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome
    Authors: Henderson, MJ;Trychta, KA;Yang, SM;Bäck, S;Yasgar, A;Wires, ES;Danchik, C;Yan, X;Yano, H;Shi, L;Wu, KJ;Wang, AQ;Tao, D;Zahoránszky-Kőhalmi, G;Hu, X;Xu, X;Maloney, D;Zakharov, AV;Rai, G;Urano, F;Airavaara, M;Gavrilova, O;Jadhav, A;Wang, Y;Simeonov, A;Harvey, BK
    Contributors: Center for Neuropsychiatric Research
    Abstract: Endoplasmic reticulum (ER) dysregulation is associated with pathologies including neurodegenerative, muscular, and diabetic conditions. Depletion of ER calcium can lead to the loss of resident proteins in a process termed exodosis. To identify compounds that attenuate the redistribution of ER proteins under pathological conditions, we performed a quantitative high-throughput screen using the Gaussia luciferase (GLuc)-secreted ER calcium modulated protein (SERCaMP) assay, which monitors secretion of ER-resident proteins triggered by calcium depletion. We identify several clinically used drugs, including bromocriptine, and further characterize them using assays to measure effects on ER calcium, ER stress, and ER exodosis. Bromocriptine elicits protective effects in cell-based models of exodosis as well as in vivo models of stroke and diabetes. Bromocriptine analogs with reduced dopamine receptor activity retain similar efficacy in stabilizing the ER proteome, indicating a non-canonical mechanism of action. This study describes a strategic approach to identify small-molecule drugs capable of improving ER proteostasis in human disease conditions.
    Date: 2021-04-27
    Relation: Cell Reports. 2021 Apr 27;35(4):Article number 109040.
    Link to: http://dx.doi.org/10.1016/j.celrep.2021.109040
    JIF/Ranking 2023: http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=2211-1247&DestApp=IC2JCR
    Cited Times(WOS): https://www.webofscience.com/wos/woscc/full-record/WOS:000644709600014
    Cited Times(Scopus): https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85105062521
    Appears in Collections:[王昀] 期刊論文

    Files in This Item:

    File Description SizeFormat
    PUB33910017.pdf6302KbAdobe PDF265View/Open


    All items in NHRI are protected by copyright, with all rights reserved.

    Related Items in TAIR

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback